Article

Applied Clinical Trials

Consider a Consultant

Hear about the benefits of bringing in an objective outsider when implementing an eCTD software.

Challenges to eCTD-The benefits of bringing in an objective outsider

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
FDA Lifts Clinical Hold on Rocket Pharmaceuticals’ Phase II Novel Investigative Gene Therapy Trial for Danon Disease
August 24th 2025

FDA Lifts Clinical Hold on Rocket Pharmaceuticals’ Phase II Novel Investigative Gene Therapy Trial for Danon Disease

Don Tracy, Associate Editor
ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials
August 24th 2025

ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials

Andy Studna, Senior Editor
How Policy Changes Could Impact Vaccine Trials and Public Participation
August 24th 2025

How Policy Changes Could Impact Vaccine Trials and Public Participation

Don Tracy, Associate Editor
© Kaikoro - © Kaikoro - stock.adobe.com
August 24th 2025

AI-Powered Non-Interventional Research Delivers What DCTs Promised

Troy Astorino
© JHVEPhoto - © JHVEPhoto - stock.adobe.com
August 24th 2025

FDA Crackdown on Trial Design: What July’s CRLs to Replimune and Capricor Mean for Sponsors

Andy Studna, Senior Editor
© JHVEPhoto - © JHVEPhoto - stock.adobe.com
August 24th 2025

FDA’s Elsa AI Tool Raises Accuracy and Oversight Concerns

Chris Mazzolini Mike Hollan
© 2025 MJH Life Sciences

All rights reserved.